Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| LMST01010052 | 3β,5α,6β-trihydroxycholestanol | Lipid-depleted/compactin | 0.0 | BCD100322A02 | 0.78 | pmol/sample |
| LMST01010052 | 3β,5α,6β-trihydroxycholestanol | Lipid-depleted/compactin | 0.5 | BCD100322A05 | 0.52 | pmol/sample |
| LMST01010052 | 3β,5α,6β-trihydroxycholestanol | Lipid-depleted/compactin | 1.0 | BCD100322A09 | 1.54 | pmol/sample |
| LMST01010052 | 3β,5α,6β-trihydroxycholestanol | Lipid-depleted/compactin | 2.0 | BCD100322A13 | 0.53 | pmol/sample |
| LMST01010052 | 3β,5α,6β-trihydroxycholestanol | Lipid-depleted/compactin | 4.0 | BCD100322A17 | 2.88 | pmol/sample |
| LMST01010052 | 3β,5α,6β-trihydroxycholestanol | Lipid-depleted/compactin | 8.0 | BCD100322A21 | 0.56 | pmol/sample |
| LMST01010052 | 3β,5α,6β-trihydroxycholestanol | Lipid-depleted/compactin | 12.0 | BCD100322A25 | 0.58 | pmol/sample |
| LMST01010052 | 3β,5α,6β-trihydroxycholestanol | Lipid-depleted/compactin | 24.0 | BCD100322A29 | - | pmol/sample |
| LMST01010052 | 3β,5α,6β-trihydroxycholestanol | C | 0.0 | BCD100322A01 | - | pmol/sample |
| LMST01010052 | 3β,5α,6β-trihydroxycholestanol | C | 0.5 | BCD100322A03 | 0.13 | pmol/sample |
| LMST01010052 | 3β,5α,6β-trihydroxycholestanol | C | 1.0 | BCD100322A07 | 0.89 | pmol/sample |
| LMST01010052 | 3β,5α,6β-trihydroxycholestanol | C | 2.0 | BCD100322A11 | 0.73 | pmol/sample |
| LMST01010052 | 3β,5α,6β-trihydroxycholestanol | C | 4.0 | BCD100322A15 | 1.63 | pmol/sample |
| LMST01010052 | 3β,5α,6β-trihydroxycholestanol | C | 8.0 | BCD100322A19 | 0.15 | pmol/sample |
| LMST01010052 | 3β,5α,6β-trihydroxycholestanol | C | 12.0 | BCD100322A23 | 0.9 | pmol/sample |
| LMST01010052 | 3β,5α,6β-trihydroxycholestanol | C | 24.0 | BCD100322A27 | 4.49 | pmol/sample |
| LMST01010052 | 3β,5α,6β-trihydroxycholestanol | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A06 | 1.02 | pmol/sample |
| LMST01010052 | 3β,5α,6β-trihydroxycholestanol | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A10 | 0.25 | pmol/sample |
| LMST01010052 | 3β,5α,6β-trihydroxycholestanol | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A14 | 1.42 | pmol/sample |
| LMST01010052 | 3β,5α,6β-trihydroxycholestanol | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A18 | 2.01 | pmol/sample |
| LMST01010052 | 3β,5α,6β-trihydroxycholestanol | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A22 | 1.31 | pmol/sample |
| LMST01010052 | 3β,5α,6β-trihydroxycholestanol | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A26 | - | pmol/sample |
| LMST01010052 | 3β,5α,6β-trihydroxycholestanol | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A30 | - | pmol/sample |
| LMST01010052 | 3β,5α,6β-trihydroxycholestanol | 25OH-Chol | 0.5 | BCD100322A04 | 0.67 | pmol/sample |
| LMST01010052 | 3β,5α,6β-trihydroxycholestanol | 25OH-Chol | 1.0 | BCD100322A08 | 1.07 | pmol/sample |
| LMST01010052 | 3β,5α,6β-trihydroxycholestanol | 25OH-Chol | 2.0 | BCD100322A12 | 0.57 | pmol/sample |
| LMST01010052 | 3β,5α,6β-trihydroxycholestanol | 25OH-Chol | 4.0 | BCD100322A16 | 0.31 | pmol/sample |
| LMST01010052 | 3β,5α,6β-trihydroxycholestanol | 25OH-Chol | 8.0 | BCD100322A20 | 0.68 | pmol/sample |
| LMST01010052 | 3β,5α,6β-trihydroxycholestanol | 25OH-Chol | 12.0 | BCD100322A24 | 1.79 | pmol/sample |
| LMST01010052 | 3β,5α,6β-trihydroxycholestanol | 25OH-Chol | 24.0 | BCD100322A28 | 0.1 | pmol/sample |